The new standard for air quality in automobiles: AELUS from Rolfhartge
• Effective protection against viruses, bacteria and fine dust through HEPA H13 filters and patented photo catalysis sluice. • Handy air cleaner for the vehicle […]
Asthma
EIB provides €20 million to support RDI activities and growth at Galenicum
The European Investment Bank (EIB) will provide €20 million to finance the research, development and innovation (RDI) programme of Galenicum, a pharmaceutical company founded in […]
Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy
• Novartis enters into exclusive worldwide license with Mesoblast to develop, commercialize and manufacture remestemcel-L for treatment of acute respiratory distress syndrome (ARDS) and other […]
Novartis Phase IIIb ARGON study meets primary endpoint in a comparison of Enerzair® Breezhaler® (QVM149)
….versus a free combination of two existing inhaled treatments in uncontrolled asthma • Once-daily Enerzair® Breezhaler® (QVM149; IND/GLY/MF) met primary endpoint, demonstrating non-inferiority to a […]